This Experimental Drug Just Received Orphan Drug Designation For Congenital Adrenal Hyperplasia
source: pixabay.com

This Experimental Drug Just Received Orphan Drug Designation For Congenital Adrenal Hyperplasia

According to a story from prnewswire.com, the experimental treatment SPR001 was just granted orphan drug status by the Food and Drug Administration (FDA). The new treatment is currently being developed…

Continue Reading This Experimental Drug Just Received Orphan Drug Designation For Congenital Adrenal Hyperplasia